FDA drafts roadmap for regulating generative AI medical devices

Credit: Harvard Medical School
Credit: Harvard Medical School

The FDA is drafting a first-ever policy roadmap for regulating medical devices powered by generative AI, according to STAT News reporter Mario Aguilar. “Our goal is formal policy guidance,” said Rick Abramson, director of the FDA’s Digital Health Center of Excellence, describing the discussion paper the agency recently released.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

A credentialing model for algorithms

The FDA is weighing a “competency-based approach” to evaluating these tools, modeled on how doctors get credentialed. The framework would cover products like AI medical chatbots, prescription-renewal tools, and diagnostic aids such as imaging or treatment-recommendation software. “You can’t regulate generative AI the way you regulate pills and cardiac pacemakers,” said David Blumenthal, a professor at the Harvard T.H. Chan School of Public Health. The plan pairs benchmarking with ongoing postmarket monitoring, since no lab test can anticipate every diagnosis an AI model might someday face.

The document isn’t a rule — it’s an invitation for public comment, so real requirements are still months away. Until then, patients and clinicians are left navigating AI tools without a clear rulebook for what counts as safe.

Related article: AI medical advice not ready for prime time
Related on the SLP
AI medical advice: Not ready for prime time

Read the original article here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

BEMT Lotion for Freckled Skin
Burned by FDA bureaucracy: Why Americans waited decades for cancer-preventing sunscreen
Nicotine Products on Gray Marble
Comparing vaping, nicotine patches and cigarettes: Not ‘safe vs. dangerous’  but ‘less harmful vs. more harmful’
Screenshot-2026-11-12-at-11.22.35-AM
The science of an orgasm: It’s a lot more varied and complex than you might think
Screenshot-2026-11-16-at-1.18.40-PM
‘Measles fiasco one of many healthcare failures’: Republican Sen. Bill Cassidy says it's time to fire RFK Jr.
Screenshot-2026-11-09-at-1.40.16-PM
As measles cases continue to surge, RFK Jr. blocks CDC scientists from issuing emergency alert warning unvaccinated pregnant women of significantly increased risks
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Man in Green “Make America Healthy Again” Cap
Viewpoint: MAHA 2.0? Will the wellness grifters rescue RFK Jr.?
Screenshot-2026-11-13-at-10.02.02-AM
Viewpoint: Why it’s such a big deal that under Trump-RFK Jr., the U.S. has lost its ‘measles-free’ status  
Contrasting Portraits and Family Story
Congressional investigation targets RFK Jr.: Documents show HHS chief lied multiple times during his confirmation hearings
Screenshot-2026-11-13-at-11.57.01-AM
JAMA survey: Who’s most likely to embrace the RFK Jr.-fueled lie that vaccines cause autism? Men, adults 35–44, blacks and Republicans
Screenshot 2026-11-13 at 11.41
Viewpoint: Talent-crushing and mired in chaos: The unnerving story of how Trump cuts are driving out disillusioned young scientists
Screenshot-2026-11-06-at-12.33.30-PM
Freaked out: Is it ethically okay to create animals with human tissue–including from the brain to help save lives?
Glossy Chocolate in Glass Petri Dish
Chocolate-making cocoa beans are increasingly in short supply. There may be a biotech fix
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.